Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand
Go back to Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand| (NASDAQ: EOLS) | Delayed: 7.75 +0.02 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.73 | 52 Week High | $ | |||
| Open | $7.76 | 52 Week Low | $ | |||
| Day High | $7.83 | P/E | N/A | |||
| Day Low | $7.67 | EPS | $ | |||
| Volume | 1,002,233 | |||||



